MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202547097420 A) filed by Juntendo Educational Foundation, Tokyo, on Oct. 9, for 't-cell receptor for hpv-specific cytotoxic t-cell, or functional fragment thereof.'
Inventor(s) include Ando, Miki; Ishii, Midori; Ando, Jun; and Nakauchi, Hiromitsu.
The application for the patent was published on Nov. 14, under issue no. 46/2025.
According to the abstract released by the Intellectual Property India: "The present invention provides a T-cell receptor, or a functional fragment thereof, that has an excellent antitumor effect, by cloning a T-cell receptor for an HPV16E6-specific cytotoxic T-cell. This T-cell receptor for an HPV16E6-specific cytotoxic T-cell, or a functional fragment thereof, has an a chain CDR3 region that comprises the amino acid sequence represented by SEQ ID NO:3 or an amino acid sequence resulting from substituting, deleting, or adding 1-3 amino acids in said amino acid sequence, and a chain CDR3 region that comprises the amino acid sequence represented by SEQ ID NO:8 or an amino acid sequence resulting from substituting, deleting, or adding 1-3 amino acids in said amino acid sequence."
The patent application was internationally filed on Mar. 15, 2024, under International application No.PCT/JP2024/010248.
Disclaimer: Curated by HT Syndication.
